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Systemic lupus erythematosus (SLE), a
chronic autoimmune disease character-
ized by overproduction of autoantibo-
dies against a series of nuclear antigens,
causes widespread tissue damage.
Although multiple genes take part in
determining the predisposition to SLE,
environmental factors, largely reflected
by epigenetic alterations, DNA methyla-
tion changes in particular, have been
demonstrated to be crucial for the
pathogenesis of SLE. DNA methylation
is a most widely studied epigenetic
mark that is stable, inheritable, and
reversible. Gene transcription can be
repressed through hypermethylation of
active promoter regions associated with
CpG-rich sequences. In contrast to gene
hypermethylation, DNA hypomethyla-
tion facilitates transcription factor bind-
ing to promoter regions, thereby
promoting gene expression.
Accumulating evidence indicates that
DNA hypomethylation in CD4þT cells
contributes to the onset and develop-
ment of drug-induced and idiopathic
lupus (Lu, 2013; Liu et al., 2013a; Liu
et al., 2013b). An array of genes,
sensitive to DNA methylation status in
their promoter regions, is overexpressed
in T cells from lupus patients, and these
gene expression levels parallel SLE
disease activity. Among the identified
targets undergoing demethylation are
genes involved in autoreactivity (ITGAL),
osmotic lysis and apoptosis (PRF1), and
B-cell/T-cell interaction (CD70 and
CD40LG). ITGAL (CD11a) has a core
role in cellular adhesion and co-stimu-
latory signaling. The CD11a overex-
pression in T-cell clones contributes to
the development of T-cell autoreactivity
in vitro, and adoptive transfer of CD11a-
overexpressed, autoreactive T cells can
induce a lupus-like disease in mice
(Richardson et al., 1994; Yung et al.,
1996). Our team has demonstrated
the increased expression of CD11a in
T cells from patients with active lupus
due to the hypomethylation of specific
sequences flanking the promoter of
ITGAL, the gene encoding CD11a
(Lu et al., 2002). The hypomethylated
CD4þT cells were also found in
patients with subacute cutaneous lupus
erythematosus (SCLE), a less severe form
of lupus, with inversely elevated CD11a
mRNA (Luo et al., 2008). Perforin,
encoded by the PRF1 gene, was
observed to be overexpressed in
CD4þT cells from patients with active
lupus as well as SCLE (Zhang et al.,
2013). The overexpression is related to
demethylation of the perforin promoter
region (Lu et al., 2003; Luo et al., 2009).
Another example of functional con-
sequence of relevant DNA hypomethy-
lation in T cells from SLE patients is the
overexpression of CD70, a cellular
ligand expressed by T cells for the TNF
receptor family member CD27 on B
cells, resulting in autologous B-cell
stimulation and IgG production (Lu
et al., 2005). Similar to CD70, CD40
ligand (CD40L) is also a B cell–
costimulatory molecule but is encoded
on the X chromosome. Epigenetic reg-
ulation, particularly DNA methylation,
has a key role in CD40L expression in
women. We previously reported that
CD40L gene is unmethylated in normal
men, while one copy of this X-chromo-
some gene is methylated and the other
is unmethylated in normal women.
Compared with normal controls, CD40L
is hypomethylated and overexpressed in
CD4þT cells from female but not male
lupus patients. With 5-azaC treatment,
the expression of CD40L doubled in
CD4þT cells from normal women but
not from men. Taken together, our
studies demonstrate that overexpression
of CD40L contributes to the pathogen-
esis of SLE in females. This is partially a
result of demethylated regulatory seq-
uences on the inactive X chromosome
in T cells (Lu et al., 2007; Zhang et al.,
2013). Besides those well-characterized
methylation-sensitive genes mentioned
above, other genes such as PP2Aca
(Sunahori et al., 2011), HRES-1 (Fali
et al., 2013), the KIR gene family (Liu
et al., 2009), LINE-1 (Sukapan et al.,
2014), and some cytokines (Mi and Zeng,
2008) are also emerging as instigators
of SLE due to abnormal methylation
patterns.
Apart from those classic methylation-
sensitive autoimmunity-related genes in
lupus CD4þT cells, the genome-wide
methylation pattern has also been
explored recently, providing us a more
full-scale picture of the abnormal
methylation patterns in SLE. Absher
et al. (2013) performed genome-wide
DNA methylation analysis with Illumina
Methylation 450 microarrays to assess
DNA methylation status in CD4þ
T cells, CD19þ B cells, and CD14þ
monocytes from SLE patients. They
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found that 166 CpGs in B cells, 97
CpGs in monocytes, and 1,033 CpGs
in T cells showed significantly altered
DNA methylation status, and that genes
involved in interferon signaling (type I)
were persistently hypomethylated. Genes
involved in cell division and MAPK
signaling in CD4þ T cells also showed
methylation changes but with a lower
amplitude shift (Absher et al., 2013).
Coit et al. (2013) also performed a
genome-wide DNA methylation study
to decipher the DNA methylome in
naive CD4þ T cells in lupus. This
study quantified DNA methylation for
over 485,000 methylation sites across
the genome, and 86 differentially
methylated CG sites in 47 genes were
identified and replicated. Significant
hypomethylation in interferon-regulated
genes was observed in naive CD4þ T
cells from lupus patients, but the hypo-
methylation was not associated with
lupus activity . However, the results of
these two studies suggest DNA methy-
lation as a mechanism for type-I inter-
feron hyper-responsiveness in lupus
T cells.
Certain miRNAs (Pan et al., 2010;
Zhao et al., 2011), such as miRNA-
126, regulatory factor X 1 (RFX1)
(Zhao et al., 2010), defective ERK path-
way signaling (Deng et al., 2003), the
growth arrest and DNA damage-
induced 45a (Gadd45a) protein (Li
et al., 2010), and DNA hydroxy-
methylation (Zhang et al., 2013) have
been proposed as potential mechanisms
leading to DNA demethylation in lupus
(Table 1). In the case of DNA
hydroxymethylation, 5-methylcytosine
(5-mC) can be converted to 5-hydroxy-
methylcytosine (5-hmC) by the ten-ele-
ven translocation (TET) family proteins,
and 5-hmC can be further oxidized into
5-formylcytosine (5fC) and 5-cyboxycy-
tosine (5caC) to achieve active DNA
demethylation (Sun et al., 2014). High
levels of TET1, TET2, and 5 hmC
were observed in CD4þT cells from
SLE patients compared with healthy
controls (Zhang et al., 2013).
A comprehensive understanding of
DNA demethylation contributing to
SLE may lead to the development of
new therapeutic agents and strategies
that target the dysregulated genes or
correct the altered methylation patterns.
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